Neurofibromatosis associated with anorexia nervosa and attention-deficit hyperactivity disorder

We report a female patient with neurofibromatosis type 1 (NF1) who developed anorexia nervosa (AN) in her early 30s. This required several admissions for weight restoration. The patient's body image concerns and experience of stigma related to the dermatological manifestations of NF1 and her misconceptions regarding the relationship between weight and NF1 appeared to be aetiological factors for AN development. This view influenced the psychotherapeutic approach she received for AN, which was successful (current body mass index =20.5 kg/m<sup>2</sup>). After being diagnosed with AN, she was diagnosed with attention-deficit hyperactivity disorder (ADHD) and successfully treated with stimulant medication (dexamphetamine) without compromising her body weight. In summary, the case illustrates that NF1 may be a risk factor for AN development and that recovery from AN is possible while treating comorbid ADHD with stimulant medications.

Authors

Institutions

Publication Details

Journal
BMJ Case Reports
Published
2025-04-01
DOI
https://doi.org/10.1136/bcr-2024-264260
Primary Topic
Neurofibromatosis and Schwannoma Cases
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Neurofibromatosis associated with anorexia nervosa and attention-deficit hyperactivity disorder

Murray G. Tucker, M. Haddad
BMJ Case Reports
Neurofibromatosis and Schwannoma Cases
article

Neurofibromatosis associated with anorexia nervosa and attention-deficit hyperactivity disorder

Murray G. Tucker, M. Haddad
article en

Abstract

We report a female patient with neurofibromatosis type 1 (NF1) who developed anorexia nervosa (AN) in her early 30s. This required several admissions for weight restoration. The patient's body image concerns and experience of stigma related to the dermatological manifestations of NF1 and her misconceptions regarding the relationship between weight and NF1 appeared to be aetiological factors for AN development. This view influenced the psychotherapeutic approach she received for AN, which was successful (current body mass index =20.5 kg/m<sup>2</sup>). After being diagnosed with AN, she was diagnosed with attention-deficit hyperactivity disorder (ADHD) and successfully treated with stimulant medication (dexamphetamine) without compromising her body weight. In summary, the case illustrates that NF1 may be a risk factor for AN development and that recovery from AN is possible while treating comorbid ADHD with stimulant medications.

BMJ Case ReportsVol. 18(4)
Barwon Health (AU), Deakin University (AU)
Good health and well-being
Openalex Percentile: Top 87%
Neurofibromatosis and Schwannoma Cases
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.